Table 1. Comparison of different medium conditions for in(CECs).
Condition | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
Medium Base | DMEM + F12 | DMEM + F12 | DMEM + F12 | DMEM + F12 | DMEM + F12 | DMEM + F12 | DMEM + F12 |
FBS | 5% | 5% | − | − | − | − | − |
Human platelet lysate | − | − | 5% PR | 5% HPR | 5% HPR | 5% PR | 5% HPR |
7.5% Sodium Bicarbonate | + | + | + | + | + | + | + |
Heparin | − | + | + | + | − | + | + |
0.5% DMSO | + | + | − | − | − | + | + |
2 ng/ml rHuEGF | + | + | − | − | − | − | − |
5 µg/ml Insulin; +5 µg/mlTransferrin; +5 ng/ml Selenium | + | + | − | − | − | − | − |
1 nM Cholera Toxin | + | + | − | − | − | − | − |
1% Amp B; +1% Pen- Strep | + | + | + | + | + | + | + |
DMEM, Dulbecco’s modified Eagle medium; PR, platelet releasate; HPR, heat-treated platelet lysate; rHuEGF, recombinant human epithelial growth factor.